Literature DB >> 3020150

Thymic B lymphocyte clones from patients with myasthenia gravis secrete monoclonal striational autoantibodies reacting with myosin, alpha actinin, or actin.

C L Williams, V A Lennon.   

Abstract

Striational autoantibodies (StrAb), which react with elements of skeletal muscle cross-striations, occur frequently in patients with thymoma associated with myasthenia gravis (MG). Dissociated thymic lymphocytes from 22 of 72 MG patients secreted StrAb when cultured with PWM. A high yield of EBV-transformed B cell lines was established from thymus, thymoma, and peripheral blood of seven patients with MG, but clones secreting StrAb arose only from the three patients who had StrAb in their sera. The monoclonal StrAb bound to A bands or I bands in skeletal muscle of human, rat, and frog. One bound to mitochondria in addition to myofibrillar I bands. None bound to nuclei, smooth muscle, or gastric mucosal cells. In immunoblot analyses and ELISAs the monoclonal StrAb bound to muscle and nonmuscle isotypes of myosin, alpha actinin, and/or actin. All bound to contractile proteins common to thymus and muscle, and one selectively immunostained epithelial cells of the thymic medulla. From these antigenic specificities we suggest that StrAb might arise as an immune response directed against the cytoskeletal anchoring proteins associated with nicotinic acetylcholine receptors in thymic epithelial cells undergoing neoplastic transformation to thymoma.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3020150      PMCID: PMC2188418          DOI: 10.1084/jem.164.4.1043

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  41 in total

1.  REACTIVITY OF MYASTHENIA GRAVIS SERUM GAMMA-GLOBULIN WITH SKELETAL MUSCLE AND THYMUS DEMONSTRATED BY IMMUNOFLUORESCENCE.

Authors:  H VAN DER GELD; T E FELTKAMP; H J OOSTERHUIS
Journal:  Proc Soc Exp Biol Med       Date:  1964-03

2.  Further studies on the specificity of presumed immune associations of myasthenia gravis and consideration of possible pathogenic implications.

Authors:  A J Strauss; C W Smith; G W Cage; H W van der Geld; D E McFarlin; M Barlow
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

3.  Autoantibodies and myasthenia gravis: epithelial cells of the thymus.

Authors:  H van der Geld; H J Oosterhuis
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

4.  Immunological concomitants of myasthenia gravis.

Authors:  A J Strauss; H W van der Geld; P G Kemp; E D Exum; H C Goodman
Journal:  Ann N Y Acad Sci       Date:  1965-06-30       Impact factor: 5.691

5.  Immunofluorescence staining patterns in skeletal muscle using serum of myasthenic patients and normal controls.

Authors:  J M Vetters
Journal:  Immunology       Date:  1965-07       Impact factor: 7.397

6.  Autoantibodies to acetylcholine receptors in myasthenia gravis.

Authors: 
Journal:  N Engl J Med       Date:  1983-02-17       Impact factor: 91.245

7.  Mammalian muscle acetylcholine receptor purification and characterization.

Authors:  C Gotti; B M Conti-Tronconi; M A Raftery
Journal:  Biochemistry       Date:  1982-06-22       Impact factor: 3.162

8.  Human erythrocyte ankyrin. Purification and properties.

Authors:  V Bennett; P J Stenbuck
Journal:  J Biol Chem       Date:  1980-03-25       Impact factor: 5.157

9.  In-vitro synthesis of anti-acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis.

Authors:  A Vincent; G K Scadding; H C Thomas; J Newsom-Davis
Journal:  Lancet       Date:  1978-02-11       Impact factor: 79.321

10.  Purification and biochemical characterization of nicotinic acetylcholine receptors of human muscle.

Authors:  M Y Momoi; V A Lennon
Journal:  J Biol Chem       Date:  1982-11-10       Impact factor: 5.157

View more
  22 in total

Review 1.  The main immunogenic region (MIR) of the nicotinic acetylcholine receptor and the anti-MIR antibodies.

Authors:  S J Tzartos; M T Cung; P Demange; H Loutrari; A Mamalaki; M Marraud; I Papadouli; C Sakarellos; V Tsikaris
Journal:  Mol Neurobiol       Date:  1991       Impact factor: 5.590

2.  Novel redistribution of myosin-containing filaments in cultured keratinocytes identified by a human monoclonal autoantibody.

Authors:  C L Williams; V A Lennon; M R Pittelkow
Journal:  In Vitro Cell Dev Biol       Date:  1989-05

3.  A pathogenetic role for the thymoma in myasthenia gravis. Autosensitization of IL-4- producing T cell clones recognizing extracellular acetylcholine receptor epitopes presented by minority class II isotypes.

Authors:  N Nagvekar; A M Moody; P Moss; I Roxanis; J Curnow; D Beeson; N Pantic; J Newsom-Davis; A Vincent; N Willcox
Journal:  J Clin Invest       Date:  1998-05-15       Impact factor: 14.808

4.  Proteins with epitopes of the acetylcholine receptor in epithelial cell cultures of thymomas in myasthenia gravis.

Authors:  A Marx; T Kirchner; F Hoppe; R O'Connor; B Schalke; S Tzartos; H K Müller-Hermelink
Journal:  Am J Pathol       Date:  1989-04       Impact factor: 4.307

5.  Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin.

Authors:  J A Aarli; K Stefansson; L S Marton; R L Wollmann
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

6.  Molecular cloning and preliminary characterization of a novel cytoplasmic antigen recognized by myasthenia gravis sera.

Authors:  T Gordon; B Grove; J C Loftus; T O'Toole; R McMillan; J Lindstrom; M H Ginsberg
Journal:  J Clin Invest       Date:  1992-09       Impact factor: 14.808

7.  Purification of actin from Candida albicans and comparison with the Candida 48,000-Mr protein.

Authors:  E Fiss; H R Buckley
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

8.  Spontaneous myocarditis mimicking human disease occurs in the presence of an appropriate MHC and non-MHC background in transgenic mice.

Authors:  Veena Taneja; Marshall Behrens; Leslie T Cooper; Satsuki Yamada; Hirohito Kita; Margret M Redfield; Andre Terzic; Chella David
Journal:  J Mol Cell Cardiol       Date:  2007-03-27       Impact factor: 5.000

9.  Non-muscle myosin as target antigen for human autoantibodies in patients with hepatitis C virus-associated chronic liver diseases.

Authors:  C A von Mühlen; E K Chan; C L Peebles; H Imai; K Kiyosawa; E M Tan
Journal:  Clin Exp Immunol       Date:  1995-04       Impact factor: 4.330

10.  Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice.

Authors:  S Spuler; A Sarropoulos; A Marx; R Hohlfeld; H Wekerle
Journal:  Am J Pathol       Date:  1996-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.